ページ内を移動するためのリンクです。

  1. ホーム
  2. 大塚製薬について
  3. Global Topics Whats & Whos
  4. 2014年
  5. Pletaal® OD Tablets' Printing Device Awarded Nakai Prize

9OCT 2014

VOL.59

  • Japan

Pletaal® OD Tablets' Printing Device Awarded Nakai Prize

Why was Otsuka awarded the Nakai Prize?

(left to right) Yoshio Hara, Manufacturing Process Development Department (Pharmaceutical Products), Otsuka Pharmaceutical Co. Ltd.; Prof. Shigeru Itai, JSPME Chairman & Prof. Uni. of Shizuoka, School of Pharmaceutical Sciences and Tadashi Mukai, Manufacturing Process Development Department, Nutraceutical Products, Otsuka Pharmaceutical Co. Ltd.

The tablet printing device developed by Otsuka Pharmaceutical Co. Ltd. was considered a revolutionary innovation because it made it possible to print clearly on uncoated tablets, including orally disintegrating tablets, which have been difficult to print on using conventional techniques.

The dramatic improvement in tablet identification made possible by this printing technology has satisfied a considerable unmet need of medical professionals and patients, and has contributed greatly to improved treatment adherence.

What is Nakai Prize?

The antiplatelet drug "Pletaal® OD Tablets 50 mg" with the printed name & dosage

In 2001, the Japan Society of Pharmaceutical Machinery and Engineering established the Nakai Prize, which is named after Yoshinobu Nakai, the first chairperson of the JSPME, in order to honor the achievements of individuals or groups who have made considerable contributions to the development of pharmaceutical machinery technology.

The Nakai Prize is awarded for achievements in either software or hardware that are judged to contribute greatly to the development and advancement of pharmaceutical machinery technology.

More articles that may interest you

最新のGlobal Topics一覧へ